October 7th 2026
As autoimmune thyroid testing grows, QC manufacturers face an increasing challenge to secure anti-TPO materials that combine reliable performance with consistent, long-term supply.
Native anti-TPO serum and plasma provide excellent clinical relevance, but high-titre material can be difficult to source. Engineered Human Fc anti-TPO antibodies offer an alternative route to greater consistency and scalable supply.
May 21st 2025
High-titre biological materials play a vital role in the development and manufacturing of in vitro diagnostic (IVD) controls and calibrators. However, sourcing bulk high-titre disease state materials presents significant challenges for Quality Control and Calibrator Manufacturers. These obstacles impact downstream processes for IVD companies, and more importantly, the patients who awaiting testing, diagnosis, and treatment.
March 19th 2025
When it comes to manufacturing quality controls (QCs), choosing the right raw material is essential. With factors like supply sustainability, cost, and performance to be considered, how do you decide whether a native or engineered biological raw material is best?
